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OBJECTIVES: Celiac disease (CD) is common and often cited as an ‘‘iceberg’’ phenomenon (i.e., an assumed large number of
undiagnosed cases). Recently, atypical or asymptomatic manifestations are becoming more commonly described in older
children and adolescents. Moreover, CD diagnosis in children can be complicated by several factors, including its diverse
clinical presentations, delay in recognizing CD signs and symptoms, and premature dietary gluten avoidance before the formal
diagnosisofCD.Todate,fewstudieshavedirectlyexaminedage-relateddifferencesinclinicalcharacteristicsandgluten-related
issuesamongchildrenwithCD.Theaimofthisstudywastodetermineage-relatedpatternsinclinicalcharacteristicsandgluten-
related issues among children with conﬁrmed CD.
METHODS: We performed a structured medical record review of biopsy-proven CD patients, aged 0–19 years, between 2000 and
2010 at a large Boston teaching hospital. Data collection included demographics, medical history, gluten-related issues, and
diagnostic investigations (CD-speciﬁc serology, upper gastrointestinal endoscopy, and small intestinal biopsy). The ﬁrst
positive duodenal biopsy with Marsh III classiﬁcation deﬁned age of diagnosis. Patients were divided into three age groups for
comparisons of the aforementioned characteristics: infant-preschool group (0–5 years), school-aged group (6–11 years), and
adolescence group (12–19 years).
RESULTS: Among 411 children with biopsy-proven CD, the mean age was 9.5 (s.d. 5.1) years. Most were female (63%) and
white (96%). All children had positive CD-speciﬁc serology. Most children presented with either abdominal complaints or bowel
movement changes.Overall,boys weremorecommon amonginfant-preschoolgroup compared withtheotherage groups.More
distinct clinical manifestations (vomiting, bowel movement changes, and weight issues) were apparent in the youngest group,
whereasschool-agedchildrenhadmoresubjectiveabdominalcomplaintsattheinitialpresentation.Conversely,theadolescents
were most likely to present without any gastrointestinal (GI) symptoms, but not when this was combined with absence of weight
issues. Age of diagnosis was not associated with atypical extraintestinal CD presentations. Regarding the gluten-related issues,
10% of school-aged children avoided dietary gluten before the formal CD diagnosis, and 27% of the adolescents reporteddietary
gluten transgression within the ﬁrst 12 months of diagnosis, signiﬁcantly higher than the other age groups. Age differences in
histopathology were also found. Whereas the infant-preschool group had a higher proportion of total villous atrophy, the older
children were more likely to have gross duodenal abnormalities and chronic duodenitis suggestive of CD at the time of
diagnosis.
CONCLUSIONS:ChildrenandadolescentswithCDhaveage-relatedpatternsinboththeclinicalpresentationsandgluten-related
issues. More pronounced clinical and histological features were determined in younger children, whereas older children more
commonly presented with solely subjective abdominal complaints or even without any GI symptoms. However, silent and
atypicalextraintestinalCDpresentationswerecomparablebetweenagegroups.Inadditiontotheaforementionedpresentations,
thehigherratesofdietaryglutenavoidanceandtransgressioninolderchildrenmakeCDdiagnosisandmanagementparticularly
challenging. These age-related patterns may further increase awareness, facilitate early diagnosis, and improve patient care of
pediatric CD.
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INTRODUCTION
Celiac disease (CD) is a genetically determined autoimmune
enteropathy with a recognized trigger of gluten and related
proteins.
1 Several studies report signiﬁcant increases in
disease prevalence in the past two decades with an
approximate prevalence of 1% in recent population screening
efforts among both children and adults in industrialized
countries;
2,3 this prevalence makes CD one of the most
common lifelong diseases in humans. Increased awareness
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www.nature.com/ctgin the community and among health-care providers on CD in
conjunction with sensitive serologic markers (tissue trans-
glutaminase antibody and endomysial antibody) for screening
high-risk patients enhance the diagnostic yield.
1,4 However,
even with highly sensitive and speciﬁc investigations, sub-
stantialnumbersofundiagnosedCDcasesremaincommonin
the pediatric population.
2,5 Nowadays, CD children have been
diagnosed at a much later age compared with the previous
decades, which could partly be because of absent or minimal
symptoms at the initial presentation in the older children and
adolescents and smaller proportion of children with classic
CD presentation.
6
Moreover, anecdotal evidence suggests that gluten avoid-
ance is relatively common among the population without
prior diagnosis of conﬁrmed CD. We recently found that the
prevalenceofCDinNewZealandchildrenwhoavoidedgluten
was ﬁve times higher than the actual doctor-diagnosed CD
(5% vs. 1%, respectively).
7 Therefore, making a deﬁnite
diagnosis of CD could be even more challenging in patients
who present with atypical or asymptomatic manifestations
and/or avoid dietary gluten before the proper diagnostic
evaluations(i.e.,serologyandintestinalbiopsy).
8Todate,few
studies have directly examined age-related clinical presenta-
tions and gluten-related issues among children with CD. Our
aim was to study this issue in a well-characterized group of
children and adolescents with positive CD-speciﬁc serology
and biopsy-conﬁrmed CD.
METHODS
We created a database of CD patients between January
2000 and December 2010 at the Massachusetts General
Hospital, a large Boston teaching hospital and referral center.
Potential cases were initially identiﬁed using ICD-9-CM
(International Classiﬁcation of Diseases, Ninth Revision,
Clinical Modiﬁcation), code 579.0, which includes celiac
disease, celiac crisis, gluten enteropathy, and nontropical
sprue. Then, structured medical record reviews were per-
formed using a data abstraction form that included demo-
graphicdata(age,gender,andrace/ethnicity)andinformation
during health-care encounters (initial presenting signs and
symptoms, patient- or parent-reported comorbid conditions,
and family history of CD and CD-related conditions).
We collected information regarding gluten-related issues
including dietary gluten avoidance before the CD diagnosis
(yes/no)anddietaryglutentransgressionveriﬁedbyadietitian
within the ﬁrst 12 months of CD diagnosis and a formal
physician’s recommendation to implement gluten-free diet
(yes/no).
Data on serologic markers, upper endoscopy, and biopsy
with histopathological information were also gathered. We
categorized children into three age groups: infant-preschool
group, 0–5 years; school-aged group, 6–11 years; and
adolescence group, 12–19 years. At our institution, we used
cutoff values of 20U/ml for tissue transglutaminase antibody
positivity and any positive titers for endomysial antibody
positivity. According to the recent ESPGHAN CD guideline,
4
most commercially available kits for tissue transglutaminase
antibody applied the cutoff values between 3 and 20U/ml; we
believe that applying 20U/ml cutoff would limit the false
positiveresults. Small intestinalbiopsysuggestiveofMarsh III
CDwasbasedontheMarsh–Oberhuberclassiﬁcation
9,10with
a reported degree of villous atrophy: partial, IIIa; subtotal, IIIb;
total, IIIc. The medical records were independently reviewed
bytwophysicians.Thestudywasapprovedbytheinstitutional
review board at our institution.
Biopsy-proven CD patients and age of CD diagnosis.
Date of CD diagnosis was deﬁned at the ﬁrst histopatho-
logical change with increased intraepithelial lymphocytes,
crypt hyperplasia, and villous atrophy from the duodenum,
which correlates with Marsh III classiﬁcation for the diagnosis
of CD. According to the then-current guideline, conﬁrmation
of the diagnosis for pediatric CD still requires small intestinal
biopsy.
8
Biostatistical analysis. We used STATA statistical
software 11.1 (StataCorp, College Station, TX). Subjects
were described using descriptive statistics, such as mean
(s.d.), median (interquartile range), and proportion (with 95%
conﬁdence interval). Comparisons of discrete variables
across different age groups were assessed using w
2 tests
or Fisher’s exact tests, when appropriate. For the continuous
variables, we used analysis of variance tests. A two-sided
Po0.05 was considered statistically signiﬁcant.
RESULTS
We identiﬁed 411 patients with biopsy-proven CD. All patients
with biopsy-proven CD had a documentation of positive
CD serology (either tissue transglutaminase antibody or
endomysial antibody). Baseline characteristics are shown in
Table 1. Age of CD diagnosis ranged from 11 months to 19
years, with 119 (29%) from the infant-preschool age group,
148(36%)fromtheschool-agegroup,and144(35%)fromthe
adolescent group. The vast majority of our patients (99%)
wereevaluatedbythe pediatricgastroenterologists beforethe
formal diagnosis of CD. As a large teaching hospital, we also
received patients with conﬁrmed positive small intestinal
biopsyforCD before the referral from outside institutions (8%)
for further evaluation and management.
Overall,mostchildrenhadsubjectiveabdominalcomplaints
or bowel movement changes. More than 40% of the children
had weight issues (weight loss or poor weight gain). We found
that 12% had neither gastrointestinal (GI) symptoms nor
weight issues. The proportions of children with atypical
extraintestinal presentations were: fatigue or malaise, 12%;
short stature or stunted height, 5%; iron deﬁciency (with or
without anemia), 3%; and elevated liver enzymes, 2%.
Regarding the past medical history, CD children were
also found to have type 1 diabetes in 6%, food allergy in
4%, hypothyroidism in 3%, and Down syndrome in 2%.
Immunoglobulin A deﬁciency (with serum immunoglobulin A
level of o7mg/dl) was found in 10 children, but all under-
went intestinal biopsy that conﬁrmed Marsh III lesion
in the duodenum. Proportions of reported positive family
history (ﬁrst- and second-degree relatives) of CD, irritable
bowel syndrome, and gastroesophageal reﬂux are shown in
Table 1.
Age-Related Patterns Among Children With Celiac Disease
Tanpowpong et al.
2
Clinical and Translational GastroenterologyWe found that 6% of the children and adolescents avoided
dietary gluten before the CD diagnosis. Furthermore, 15% of
biopsy-conﬁrmed CD patients had gluten transgression within
the ﬁrst year of diagnosis.
Demographics. Age-related patterns of CD manifestations
among children of three different age groups are also shown
in Table 1. Overall, CD children in the infant-preschool group
had a higher male percentage compared with the school-
aged and adolescence groups. There were no signiﬁcant
race/ethnicity differences across the three age groups;
however, the proportion of non-white patients in the study
population was small (4%).
Clinical presentations. Two-thirds of the school-aged
group had complaints of subjective abdominal complaints
(pain, discomfort, gas, and bloating) at the initial presen-
tation, which was more common than the other two groups.
Generally, females more frequently had abdominal pain
compared with males with borderline signiﬁcance (48% vs.
38%, P¼0.051). More pronounced GI presentations such as
abdominal distention, vomiting, bowel movement changes,
or weight issues (weight loss or poor weight gain) were
more common in the younger age group. This group also
more commonly presented with a prior biopsy-proven CD
diagnosis before the referral to our institution. Conversely,
the adolescence group had a signiﬁcantly higher proportion
of patients with an absence of GI symptoms. No signiﬁcant
difference was found when comparing male and female
patients without GI symptoms (18% vs. 15%, P¼0.34).
However, after combining the absence of GI symptoms and
absence of weight issues (i.e., silent CD), no statistically
signiﬁcant differences between age groups were found.
Moreover, there were no age-related differences in atypical
extraintestinal presentations or nonspeciﬁc complaints (i.e.,
poor sleep, poor appetite; all P40.20). None of our patients
had a documented history of dermatitis herpetiformis.
Past medical history and family history. Besides a
borderline signiﬁcant higher rate of history of food allergy
among infant-preschool children, no age-related differences
were found in other comorbid conditions including type 1
diabetes (P¼0.27), hypothyroidism (P¼0.46), gastroeso-
phageal reﬂux (P¼0.30), and Down syndrome (P¼0.37).
Age-related patterns in reported positive family history of CD,
irritable bowel syndrome, and gastroesophageal reﬂux are
shown in Table 1. We found signiﬁcantly higher proportion of
school-aged children with reported positive family history of
CD, and borderline higher proportion with positive family
history of irritable bowel syndrome in the same age group.
We also noted that female CD patients were approximately
three times more likely to have a family history of irritable
bowel syndrome than the male individuals (11% vs. 3%
respectively, P¼0.007).
Gluten-related issues (dietary gluten avoidance and
transgression). A total of 10% of school-aged children
avoided dietary gluten before the formal CD diagnosis was
made, and this rate was two times higher than the infant-
preschool group and ﬁve times higher than the adolescence
Table 1 Baseline demographics and clinical presentations of 411 children with celiac disease, by age of diagnosis
Characteristics All cases
(n¼411)
Age of diagnosis P value
0–5 Years
(n¼119)
6–11 Years
(n¼148)
12–19 Years
(n¼144)
Demographics
Age of diagnosis, median (interquartile range), years 9.3 (5.3–13.7) 3.3 (2.1–4.9) 8.7 (7.3–10.1) 14.9 (13.5–16.8) —
% (95% conﬁdence interval)
Male, % 37 (32–42) 46 (37–56) 32 (25–41) 33 (26–42) 0.04
Non-Hispanic white, % 96 (94–98) 96 (90–99) 99 (95–100) 94 (89–98) 0.15
Clinical presentations
Abdominal complaints, % (pain, discomfort, gas, bloating) 60 (55–64) 51 (42–61) 68 (59–75) 56 (47–64) 0.02
Abdominal pain, % 45 (40–50) 27 (19–36) 58 (49–66) 46 (37–54) o0.001
Abdominal distention, % 9 (7–12) 20 (13–29) 5 (2–11) 4 (1–8) o0.001
Vomiting, % 20 (15–25) 34 (23–47) 15 (8–23) 15 (8–24) 0.03
Bowel movement changes, % 53 (47–58) 68 (58–77) 50 (41–59) 43 (34–53) 0.001
Diarrhea (without constipation), % 24 (20–29) 31 (22–41) 20 (13–28) 22 (15–31) 0.01
Constipation (without diarrhea), % 20 (16–25) 25 (17–35) 21 (14–29) 16 (9–23) 0.02
Alterations of diarrhea and constipation, % 9 (6–12) 12 (7–21) 9 (4–15) 5 (2–11) 0.02
Weight issues, % (weight loss or poor weight gain) 43 (37–48) 56 (45–67) 34 (25–44) 39 (30–48) 0.006
Diagnosed celiac disease before a referral, % 8 (5–10) 12 (7–19) 3 (1–8) 8 (4–14) 0.03
Absence of gastrointestinal symptoms, % 16 (12–20) 8 (4–15) 16 (11–23) 21 (15–29) 0.02
Absence of gastrointestinal symptoms and weight
issues (i.e., silent presentation), %
12 (9–16) 8 (4–14) 12 (7–19) 16 (10–23) 0.14
Atypical extraintestinal presentations
a, % 20 (16–24) 16 (10–24) 19 (13–27) 24 (17–32) 0.25
Past medical history and family history
History of food allergy, % 4 (3–7) 7 (3–13) 5 (2–11) 1 (0–5) 0.07
Family history of celiac disease, % 19 (16–23) 12 (7–19) 27 (20–35) 18 (12–25) 0.01
Family history of irritable bowel syndrome, % 8 (6–11) 7 (3–13) 12 (7–19) 5 (2–10) 0.06
Family history of gastroesophageal reﬂux, % 12 (9–15) 11 (6–18) 13 (8–20) 11 (6–17) 0.81
aIncluding fatigue/malaise, short stature or stunted height, iron deﬁciency, and elevated liver enzymes.
Age-Related Patterns Among Children With Celiac Disease
Tanpowpong et al.
3
Clinical and Translational Gastroenterologygroup. No children in the study underwent gluten restriction-
rechallenge process before the ﬁnal CD diagnosis was
made. Within the ﬁrst 12 months of CD diagnosis and formal
physician’s recommendation to implement gluten-free diet,
more than a quarter of the adolescence group reported
dietary gluten transgression (either intentional or uninten-
tional), which was approximately three times more often than
the two younger age groups.
Upper endoscopy and small intestinal biopsy. Almost
half (48%) of the children had an abnormal antral biopsy,
and 18% had abnormalities in the distal esophageal biopsy,
most with increased eosinophils suggestive of reﬂux injury.
The older children were more likely to have gross duodenal
abnormalities suggestive of CD (either ﬂat, scalloping, or
nodularity) and chronic duodenitis on biopsy at the time of
diagnosis (Table 2). On the other hand, both the total villous
atrophy (Marsh IIIc) and increased antral intraepithelial
lymphocytes were more likely in the infant-preschool group,
but proportions of diagnosed lymphocytic gastritis were
comparable (P¼0.09).
DISCUSSION
The iceberg phenomenon of CD (i.e., an assumed large
number of undiagnosed cases) remains an important concern
in children and adolescents despite increased disease
prevalence and awareness, highly sensitive and speciﬁc CD
serologic markers, and improved accessibility of upper GI
endoscopy and biopsy.
2,5 Atypical or asymptomatic mani-
festations undoubtedly contribute to this phenomenon
by decreased awareness among patients, caregivers, and
health-care professionals.
11 Moreover, diagnosing CD
can be further challenged by premature implementation of
dietary gluten avoidance before the deﬁnite diagnosis is
made.
8 Anecdotal evidence suggests that gluten avoidance is
relatively prevalent in the community, and we recently found
that 5% of New Zealand children in the population-based
study avoided gluten, whereas the prevalence of diagnosed
CD was similar to other industrialized countries (1%).
7 To
date, there is no evidence in the scientiﬁc literature to suggest
the precise amount of ingested gluten that elicits a measur-
ablemucosalresponse.Moreover,availablestudiesongluten
avoidance in the general population (without prior CD
diagnosis) are very limited.
Some previous data exist on the different age-related
patterns of CD presentations in children vs. adults. Vivas
et al.
12 prospectively examined 66 CD children with the mean
age of 3.6 years with two-thirds o2 years of age, and most
young children presented with more pronounced symptoms
and severe villous atrophy. However, the current evidence
showed that pediatric CD are diagnosed at a later age with
less apparent clinical manifestations.
6 To our knowledge, this
is the ﬁrst study to directly examine both the clinical
presentations and gluten-related issues among pediatric CD
patients of different age groups.
Among 411 biopsy-proven CD children and adolescents
with positive CD serology, various age-related characteristics
were detected; the previous study had suggested that
interobserver agreement is substantial when combining
positive serology and positive Marsh III biopsy for the CD
diagnosis.
13 Overall, higher male percentage was found in
the infant-preschool age group. A simple explanation for this
gender difference is elusive but may relate to dissimilar
hormonalandimmuneresponsestoinjuryandinﬂammationin
the presence of gluten introduction during early childhood;
related gender differences have been observed in other
immune system-mediated disorders.
14,15
Regarding the clinical manifestations, the school-aged and
adolescence groups more frequently presented with non-
speciﬁc abdominal complaints. Moreover, the absence of GI
symptoms was also more commonly noticed in the older
children.However,oncombiningtheabsenceofGIsymptoms
and absence of weight issues (i.e., silent CD), the statistical
signiﬁcance on the age-related patterns disappeared
(Table 1), which differs from earlier studies.
6,11 Furthermore,
nosigniﬁcantdifferenceswerefoundinatypicalextraintestinal
CD presentations. The proportions of children with iron
deﬁciency and elevated liver enzymes were comparable to
the prior study.
12 The infant-preschool group not only had
more prominent clinical presentations, similar to prior
studies,
6,12 but also were more likely to be diagnosed with
biopsy-proven CD before the referral to our institution.
Possible explanations to the latter ﬁnding include more
Table 2 Gluten-related issues and upper endoscopy and small intestinal biopsy ﬁndings in celiac disease patients, by age of diagnosis
Characteristics Data
available (n)
All cases Age of diagnosis P value
0–5 Years 6–11 Years 12–19 Years
Gluten-related issues % (95% conﬁdence interval)
Dietary gluten avoidance before formal celiac disease
diagnosis, %
341 6 (4–9) 5 (2–12) 10 (6–17) 2 (0–6) 0.02
Dietary gluten transgression within the ﬁrst 12 months
after diagnosis, %
384 15 (11–20) 10 (5–18) 9 (4–16) 27 (19–37) o0.001
Upper endoscopy and small intestinal biopsy
Documented gross duodenal abnormalities, % 392 68 (63–73) 58 (48–67) 71 (62–78) 74 (65–81) 0.02
Chronic duodenitis on biopsy, % 396 23 (19–28) 17 (10–25) 22 (15–29) 30 (22–38) 0.045
Total villous atrophy (Marsh IIIc), % 411 32 (25–38) 46 (33–59) 27 (17–38) 24 (15–35) 0.02
Increased antral intraepithelial lymphocytes, % 387 10 (7–14) 18 (11–26) 7 (3–12) 8 (3–12) 0.006
Chronic antral gastritis, % 387 32 (26–37) 30 (22–40) 30 (23–38) 35 (27–43) 0.69
Increased eosinophils in the distal esophagus, % 378 12 (9–16) 13 (7–20) 13 (8–19) 12 (7–19) 0.99
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andtendencytoreferpatients withmoresevere presentations
to a tertiary care center. Regarding the bowel movement
issues,wefoundthatarelativelyhighpercentage(20%)ofCD
children presented with constipation, compared with prior
studies.
16,17 The infant-preschool group not only had more
children with diarrhea (without constipation) but also higher
proportions of constipation and alterations of both when
compared with the older children (Table 1), although the
previous review suggested that constipation is more common
in older children and adolescents with CD.
11 These disparities
might possibly be because of various reporting and/or referral
issues by the caregivers and health-care providers, a
possibility that requires further investigation. Generally, the
youngerchildrencouldlikelyhavelimitedcapabilitytoexpress
subjective symptoms when compared with the older indivi-
duals. Natural courses, environmental factors (e.g., breast-
feeding and gluten introduction), and disease pathogenesis
could be different between younger and older children.
We found a borderline signiﬁcant higher proportion of
reported food allergy in the youngest group. Both CD and
food allergy are prevalent and increasingly diagnosed in
children.
6,18 These two conditions can both present with
nonspeciﬁc GI symptoms such as vomiting and/or diarrhea in
infantsandyoungchildren.
19Therefore,health-careproviders
might initially diagnose these children with presumed food
allergy before completing CD evaluation in suspected cases.
The signiﬁcant age-related differences in family history of CD
were interesting but difﬁcult to explain. School-aged children
and adolescents, who were more likely to have no or less
typical CD symptoms, might also be more likely to undergo
CD screening solely because of positive family members with
CD compared with the younger children. The similar reason
might explain the borderline signiﬁcant higher proportion of
family history of irritable bowel syndrome among the school-
aged children as well. Another possible explanation might be
because of differences in parental or patient reports across
the age groups. These questions will need to be addressed
with future research.
Notably, we found that dietary gluten avoidance before
the formal CD diagnosis is common in children (6%), with
the higher proportion among school-aged children up to 10%,
although the current CD prevalence is B1% in the general
pediatric population.
2 As the school-aged group more
commonly presented with nonspeciﬁc abdominal complaints,
caregivers or health-care providers might implement dietary
gluten restriction as a therapeutic trial to alleviate these
symptoms. Recent evidence suggested that nonceliac gluten
intolerance exists in adults.
20 Contrary, the adolescents were
lesslikelytoavoidglutenbeforeCDdiagnosis,whichmightbe
because of increased identity, independence, and distinctive
peer interaction during this stage of development. The similar
grounds could also explain the high rates (27%) of dietary
gluten transgression within the ﬁrst year of CD diagnosis in
this age group. An investigation on decisions to implement
and continue dietary gluten avoidance among patients,
caregivers, and health-care professionals would be valuable
to explain these ﬁndings.
At the initial CD diagnosis, the more prominent histological
features (total villous atrophy (Marsh IIIc) and increased antral
intraepithelial lymphocytes) at diagnosis were found among the
infant-preschool group, similar to the prior reports.
11,12 One
study showed that children with increased gastric intraepithelial
lymphocytes are more likely to be diagnosed at an earlier age,
and present with more pronounced laboratory and duodenal
mucosal abnormalities.
21 The recent study also showed
decreased proportions of CD children diagnosed in 2000–2006
with total villous atrophy when compared with individuals who
werediagnosedduringthepreviousdecade.
6Ontheotherhand,
older children were more likely to have grossly visible and
chronic changes in the duodenum, which might be because of
diverse immune responses and histopathological changes
between age groups (i.e., timing of CD diagnosis).
This study has some potential limitations. The study was
conducted in a retrospective fashion at a large teaching
hospital. Although we acknowledge the possibility of incom-
plete information (e.g., anthropometric data), both recall and
informationbiasesaswellastheinabilitytocontrolforallofthe
parent- or patient-reported data with the physicians’ inter-
pretation, we believe that our novel ﬁndings will provide a
platform for the development of age-related approaches for
evaluation and management of CD. Prior evidence suggests
that delay in CD diagnosis is correlated with the patient’s
age;
12 in other words, there will tend to be more delay in older
children (which might be subject to more recall biases), as
compared with younger children. With regard to parental
(proxy)reporting,thelimitedcommunicationabilitiesofinfants
and younger children have inevitably restricted expression of
subjective symptoms in this group. Therefore, both research-
ers (and clinicians) need to rely on the parental reports for the
clinical presentations of younger children. We are also well
aware that cutoff ages for ‘‘pediatric’’ and ‘‘adolescent’’
population can be varied between different geographic areas.
We decided to employ 19 years of age as a cutoff year based
on social environment and culture on development (according
to the Erikson’s stage of development) that would mainly be
applied to the aforementioned gluten-related issues.
Itisnoteworthythatallstudypatientswereevaluatedbefore
release of the recent 2012 CD guideline,
4 and we still believe
that it was most appropriate to apply the then-current
NASPGHAN 2005 guideline, especially in these North Amer-
ican children and adolescents.
8 We also note that the issue of
nonbiopsy diagnosis in CD remains debatable.
22 Furthermore,
all patients had documentation of both positive CD-speciﬁc
serology and biopsy, as we believe, in this situation, that
genetic markers would not play an important role in assisting
CD diagnosis.
4,8 The data on gluten-related issues were
obtainedinaqualitativeway(yes/no)fromthemedicalrecords.
As a generally accepted strategy, patients who undergo CD
evaluations should consume regular gluten-containing diet
while obtaining serology and biopsy to increase the yield of
diagnosis and limit potential false negative results.
8 Gluten
avoidance can also result in several disadvantageous effects
on the quality of life,
23 self-perceived health,
24 psychosocial
dynamics,
25 nutritional status,
26 and increased economic
health burden.
27 Moreover, the proportions of dietary gluten
transgression in our study were comparable to most previous
studies.
28–30 Currently, strict lifelong gluten-free diet remains
the only effectivemanagementinCD. Asa result,the historyof
gluten restriction before making a deﬁnite diagnosis and any
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unsuitable in the processes of proper evaluation and manage-
ment of CD, respectively.
In summary, we describe the age-related patterns in both
the clinical presentations and gluten-related issues among
childrenandadolescentswithCD.Causalexplanationsforthe
observed ﬁndings will require further studies that address
potentially different disease pathogenesis, diagnostic and
referral patterns, and decisions to implement and maintain
gluten avoidance by age. We found that whereas the
vast majority of children and adolescents presented with
subjective abdominal complaints or bowel movement issues,
older children more commonly presented with subjective or
vague abdominal complaints or an absence of GI symptoms.
However, silent (i.e., absence of both GI symptoms and
weight issues) and atypical extraintestinal CD presentations
were comparable between age groups. Furthermore, pre-
mature gluten avoidance before the CD diagnosis in school-
aged children and dietary gluten transgression after the CD
diagnosis in adolescents were common. These clinical and
gluten-relatedfactorsmakethediagnosisandmanagementof
CD in older children particularly challenging. We believe that
these age-related patterns may further increase awareness,
facilitate early recognition and diagnosis, and improve patient
care of pediatric CD.
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Study Highlights
WHAT IS CURRENT KNOWLEDGE
|Celiac disease (CD) is one of the most common
lifelong disorders in children.
|‘‘Iceberg’’ phenomenon also remains a major problem
in children, and may result from atypical or even
asymptomatic manifestations.
|Recent study showed high rates of children who
avoided gluten without diagnosed CD.
|Few studies have directly examined age-related patterns
in both the clinical presentations and gluten-related
issues among children and adolescents with CD.
WHAT IS NEW HERE
|Most children present with either subjective abdominal
complaints or bowel movement changes.
|Although older children are more likely to present
nonspeciﬁc abdominal complaints, the frequency of
silent and atypical extraintestinal CD presentations
does not differ by age.
|High rates of gluten avoidance before CD diagnosis
are noted in school-aged children.
|Diagnosing and managing CD in the older children
may be more challenging.
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